Rapport Therapeutics, Inc. (RAPP)
30.74
+0.89
(+2.98%)
USD |
NASDAQ |
Oct 09, 16:00
30.74
0.00 (0.00%)
After-Hours: 18:22
Rapport Therapeutics Market Cap : 1.474B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.431B |
| October 07, 2026 | 1.480B |
| October 06, 2026 | 1.494B |
| October 05, 2026 | 1.544B |
| October 02, 2026 | 1.543B |
| October 01, 2026 | 1.574B |
| September 30, 2026 | 1.611B |
| September 29, 2026 | 1.583B |
| September 28, 2026 | 1.604B |
| September 25, 2026 | 1.626B |
| September 24, 2026 | 1.622B |
| September 23, 2026 | 1.637B |
| September 22, 2026 | 1.989B |
| September 21, 2026 | 1.902B |
| September 18, 2026 | 1.940B |
| September 17, 2026 | 2.012B |
| September 16, 2026 | 1.985B |
| September 15, 2026 | 2.047B |
| September 14, 2026 | 2.110B |
| September 11, 2026 | 2.092B |
| September 10, 2026 | 2.084B |
| September 09, 2026 | 2.105B |
| September 08, 2026 | 2.210B |
| September 04, 2026 | 2.195B |
| September 03, 2026 | 2.285B |
| Date | Value |
|---|---|
| September 02, 2026 | 2.335B |
| September 01, 2026 | 2.329B |
| August 31, 2026 | 2.334B |
| August 28, 2026 | 2.339B |
| August 27, 2026 | 2.438B |
| August 26, 2026 | 2.518B |
| August 25, 2026 | 2.454B |
| August 24, 2026 | 2.366B |
| August 21, 2026 | 2.313B |
| August 20, 2026 | 2.295B |
| August 19, 2026 | 2.353B |
| August 18, 2026 | 2.350B |
| August 17, 2026 | 2.322B |
| August 14, 2026 | 2.274B |
| August 13, 2026 | 2.271B |
| August 12, 2026 | 2.289B |
| August 11, 2026 | 2.341B |
| August 10, 2026 | 2.253B |
| August 07, 2026 | 2.181B |
| August 06, 2026 | 2.223B |
| August 05, 2026 | 2.035B |
| August 04, 2026 | 2.024B |
| August 03, 2026 | 1.956B |
| July 31, 2026 | 1.959B |
| July 30, 2026 | 2.045B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.698B |
| Corcept Therapeutics, Inc. | 13.07B |
| Veru, Inc. | 42.20M |
| Johnson & Johnson | 628.14B |
| Eli Lilly & Co. | 1.110T |
Market Cap Related Metrics
| PS Ratio | 69.02 |
| PEG Ratio | -0.4295 |
| Price to Book Value | 3.486 |
| Price | 30.74 |
| Earnings Yield | -9.89% |
| PEGY Ratio | -0.4295 |